4578.T
4578.T
JP3188220002
OTSUKA HLDGS CO LTD
Loading chart...

Company Profile

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.

Related stocks

4568.T
4568.T • Japan
DAIICHI SANKYO COMPANY LIMITED
2,623 JPY
30.16B USD 1Y -37.2%
4503.T
4503.T • Japan
ASTELLAS PHARMA
2,247.5 JPY
25.47B USD 1Y +35.2%
4519.T
4519.T • Japan
CHUGAI PHARMACEUTICAL CO
6,019 JPY
62.6B USD 1Y -18.1%
4528.T
4528.T • Japan
ONO PHARMACEUTICAL CO
2,259 JPY
6.71B USD 1Y +22%
4536.T
4536.T • Japan
SANTEN PHARMACEUTICAL CO
1,684 JPY
3.42B USD 1Y +7.8%
002422.SZ
002422.SZ • China
KELUN PHARMA
39.72 CNY
9.45B USD 1Y +10.1%
600436.SS
600436.SS • China
ZHANGZHOU PIENTZEHUANG PHARMACE
119.82 CNY
10.82B USD 1Y -38.9%
1093.HK
1093.HK • China
CSPC PHARMA
9.09 HKD
13.2B USD 1Y -3.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
26.4% p.a.
Max Drawdown (5Y)
-32.0%
Sharpe Ratio (5Y)
0.64
Beta Factor
-0.02
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
ende